These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38835082)

  • 1. The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms.
    Ogawa S; Tayama J; Murota H; Kobayashi M; Kinoshita H; Nakamichi S
    Biopsychosoc Med; 2024 Jun; 18(1):14. PubMed ID: 38835082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of primary focal hyperhidrosis with anxiety induced by sweating: A cross-sectional study of Japanese university students focusing on the severity of hyperhidrosis and site of sweating.
    Ogawa S; Tayama J; Murota H; Kobayashi M; Kinoshita H; Nishino T
    J Dermatol; 2023 Mar; 50(3):364-374. PubMed ID: 36282908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperhidrosis: Implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin.
    Shayesteh A; Boman J; Janlert U; Brulin C; Nylander E
    J Dermatol; 2016 Aug; 43(8):928-33. PubMed ID: 26875781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system.
    Donhauser T; Gabes M; Özkan E; Masur C; Kamudoni P; Salek S; Abels C; Apfelbacher C
    Br J Dermatol; 2024 Mar; 190(4):519-526. PubMed ID: 38015827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.
    Nelson LM; DiBenedetti D; Pariser DM; Glaser DA; Hebert AA; Hofland H; Drew J; Ingolia D; Gillard KK; Fehnel S
    J Patient Rep Outcomes; 2019 Sep; 3(1):59. PubMed ID: 31486951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
    Kirsch BM; Burke L; Hobart J; Angulo D; Walker PS
    J Drugs Dermatol; 2018 Jul; 17(7):707-714. PubMed ID: 30005091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).
    Kamudoni P; Mueller B; Salek MS
    Qual Life Res; 2015 Apr; 24(4):1017-27. PubMed ID: 25367139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Hospital Anxiety and Depression Scale in an Indonesian population: a scale adaptation study.
    Tiksnadi BB; Triani N; Fihaya FY; Turu' Allo IJ; Iskandar S; Putri DAE
    Fam Med Community Health; 2023 Jun; 11(2):. PubMed ID: 37277187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Fear of Negative Evaluation scale (FNE): psychometric properties of the French version].
    Musa C; Kostogianni N; Lépine JP
    Encephale; 2004; 30(6):517-24. PubMed ID: 15738853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Danish Hospital Anxiety and Depression Scale in patients with cardiac disease: results from the DenHeart survey.
    Christensen AV; Dixon JK; Juel K; Ekholm O; Rasmussen TB; Borregaard B; Mols RE; Thrysøe L; Thorup CB; Berg SK
    Health Qual Life Outcomes; 2020 Jan; 18(1):9. PubMed ID: 31910859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.
    Gabes M; Jourdan C; Schramm K; Masur C; Abels C; Kamudoni P; Salek S; Apfelbacher C
    Br J Dermatol; 2021 Mar; 184(3):473-481. PubMed ID: 32510573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperhidrosis and anxiety: a prospective preoperative survey of 158 patients].
    Ramos R; Moya J; Turón V; Pérez J; Villalonga R; Morera R; Perna V; Ferrer G
    Arch Bronconeumol; 2005 Feb; 41(2):88-92. PubMed ID: 15718003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Anxiety Inventory for Respiratory Disease in patients with COPD in China.
    Dong XY; Wang L; Tao YX; Suo XL; Li YC; Liu F; Zhao Y; Zhang Q
    Int J Chron Obstruct Pulmon Dis; 2017; 12():49-58. PubMed ID: 28053516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhidrosis - Sweating Sites Matter: Quality of Life in Primary Hyperhidrosis according to the Sweating Sites Measured by SF-36.
    Shayesteh A; Janlert U; Nylander E
    Dermatology; 2017; 233(6):441-445. PubMed ID: 29502112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The reliability and validity of Turkish Brief Measure of Worry Severity based on Turkish university students].
    Tunay S; Soygüt G
    Turk Psikiyatri Derg; 2009; 20(1):68-74. PubMed ID: 19306128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Turkish version of caregiver self-assessment questionnaire.
    Aşkın A; Atar E; Şengül İ; Tosun A; Demirdal Ü; Elmalı F
    Disabil Rehabil; 2020 Nov; 42(22):3250-3255. PubMed ID: 30990351
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the serum magnesium and vitamin D levels and the risk of anxiety in primary hyperhidrosis.
    Manav V; Türk CB; Kara Polat A; Erdil D; Baş S; Koku Aksu AE
    J Cosmet Dermatol; 2022 Jan; 21(1):373-379. PubMed ID: 33738914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life in Patients with Focal Hyperhidrosis before and after Treatment with Botulinum Toxin A.
    Kouris A; Armyra K; Christodoulou C; Karimali P; Karypidis D; Kontochristopoulos G
    ISRN Dermatol; 2014; 2014():308650. PubMed ID: 24891956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.